Skip to main content
. 2021 Jul 21;2021:3984463. doi: 10.1155/2021/3984463

Figure 9.

Figure 9

The ex vivo validation of BLACAT1, hsa-miR-146b-3p, hsa-miR-214-3p, and MMRN1 in 7 PTC patients. Fold change > 1 and fold change < 1 represent upregulation and downregulation, respectively. ∗∗p < 0.01.